Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services company information, Employees & Contact Information

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India, providing support across gene therapy, APIs, and both large and small molecule manufacturing. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com

Company Details

Employees
620
Address
15-1, Kyobashi 1-Chome, Chuo-Ku,tokyo 104-8315,japan
Phone
+1-858-882-0123
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
| LinkedIn.
HQ
Chuo-ku, Tokyo
Looking for a particular Ajinomoto Bio-Pharma Services employee's phone or email?

Ajinomoto Bio-Pharma Services Questions

News

Aji Bio-Pharma, Olon Partner to Deliver Drug Substance Manufacturing Services - Contract Pharma

Aji Bio-Pharma, Olon Partner to Deliver Drug Substance Manufacturing Services Contract Pharma

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing - PR Newswire

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing PR Newswire

Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards - PR Newswire

Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards PR Newswire

Boyd Releases “Global Biomanufacturing Costs” Report - Contract Pharma

Boyd Releases “Global Biomanufacturing Costs” Report Contract Pharma

CDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant - Fierce Pharma

CDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant Fierce Pharma

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea Business Wire

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection - Nasdaq

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Nasdaq

Belgium's Ajinomoto doubles Indian small-molecule manufacturing cap with new facility - Fierce Pharma

Belgium's Ajinomoto doubles Indian small-molecule manufacturing cap with new facility Fierce Pharma

The Paradigm Shift To Continuous Flow Processes: A Holistic View - Bioprocess Online

The Paradigm Shift To Continuous Flow Processes: A Holistic View Bioprocess Online

AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production - ACS Publications

AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production ACS Publications

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics - PR Newswire

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics PR Newswire

A CDMO for the Future: Adapting Services for Evolving Needs - Fierce Pharma

A CDMO for the Future: Adapting Services for Evolving Needs Fierce Pharma

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility - PR Newswire

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility PR Newswire

Contracting & Outsourcing 2024: Q&A with Brian McCollum of Glatt - Contract Pharma

Contracting & Outsourcing 2024: Q&A with Brian McCollum of Glatt Contract Pharma

Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign - Fierce Pharma

Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign Fierce Pharma

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing - PR Newswire

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing PR Newswire

First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval - PR Newswire

First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval PR Newswire

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer - PR Newswire

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer PR Newswire

Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines - PR Newswire

Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines PR Newswire

SomaLogic Expands Agreement with Novo Nordisk to 2025 - Contract Pharma

SomaLogic Expands Agreement with Novo Nordisk to 2025 Contract Pharma

Granules JV in India OmniChem acquired by Ajinomoto Bio-Pharma - Medical Dialogues

Granules JV in India OmniChem acquired by Ajinomoto Bio-Pharma Medical Dialogues

Ajinomoto Bio-Pharma buys Indian API plant - BioSpectrum Asia

Ajinomoto Bio-Pharma buys Indian API plant BioSpectrum Asia

WuXi AppTec Opens South Korea Office - Contract Pharma

WuXi AppTec Opens South Korea Office Contract Pharma

Ajinomoto Bio-Pharma Services expands India facility - BioSpectrum India

Ajinomoto Bio-Pharma Services expands India facility BioSpectrum India

BD Appoints R&D SVP - Contract Pharma

BD Appoints R&D SVP Contract Pharma

Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology - ACS Publications

Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology ACS Publications

XOMA, Taligen Enter Manufacturing Deal - Contract Pharma

XOMA, Taligen Enter Manufacturing Deal Contract Pharma

Top Ajinomoto Bio-Pharma Services Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant